OPKO Health Inc (OPK) - Financial and Strategic SWOT Analysis Review

OPKO Health Inc (OPK) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH41384FSA
  • |
  • Pages: 52
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

OPKO Health Inc (OPK)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

OPKO Health Inc (OPKO) discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals. The company's product portfolio includes point-of-care tests, laboratory developed tests (LDTs), molecular diagnostics tests, and proprietary pharmaceuticals and vaccines. It offers its diagonostics and therapeutics that are used in the treatment of chronic kidney disease, obesity, asthma, chronic obstructive pulmonary disease (COPD), cancer and chemotherapy-induced nausea and vomiting, among others. It also offers neutraceuticals and veterinary products.The company also offers contract research services to other pharmaceutical companies. The company has its operational presence with its offices located in Chile, Mexico, Spain, Ireland, Canada and Israel. OPKO is headquartered in Miami, Florida, the US.

OPKO Health Inc Key Recent Developments

Sep 07,2018: SEC Charges Microcap Fraudsters for Roles in Lucrative Market Manipulation Schemes

Aug 07,2018: Opko Health announces second quarter 2018 financial results

May 08,2018: OPKO Health Announces First Quarter 2018 Financial Results

May 01,2018: OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories

Mar 01,2018: OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

OPKO Health Inc-Key Facts 6

OPKO Health Inc-Key Employees 7

OPKO Health Inc-Key Employee Biographies 8

OPKO Health Inc-Major Products and Services 9

OPKO Health Inc-History 10

OPKO Health Inc-Company Statement 13

OPKO Health Inc-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 17

Company Overview 17

OPKO Health Inc-Business Description 18

Business Segment: Diagnostics 18

Overview 18

Performance 18

Key Stats 18

Business Segment: Pharmaceutical 18

Overview 18

Performance 18

Geographical Segment: Chile 18

Performance 18

Geographical Segment: Ireland 19

Performance 19

Geographical Segment: Israel 19

Performance 19

Geographical Segment: Mexico 19

Performance 19

Geographical Segment: Other Countries 19

Performance 19

Geographical Segment: Spain 19

Performance 19

Geographical Segment: the US 19

Performance 19

R&D Overview 19

OPKO Health Inc-Corporate Strategy 21

OPKO Health Inc-SWOT Analysis 22

SWOT Analysis-Overview 22

OPKO Health Inc-Strengths 22

OPKO Health Inc-Weaknesses 23

OPKO Health Inc-Opportunities 24

OPKO Health Inc-Threats 25

OPKO Health Inc-Key Competitors 26

Section 3-Company Financial Ratios 27

Financial Ratios-Capital Market Ratios 27

Financial Ratios-Annual Ratios 28

Performance Chart 30

Financial Performance 30

Financial Ratios-Interim Ratios 31

Financial Ratios-Ratio Charts 32

Section 4-Company's Lifesciences Financial Deals and Alliances 33

OPKO Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

OPKO Health Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 34

OPKO Health Inc, Recent Deals Summary 35

Section 5-Company's Recent Developments 36

Sep 07, 2018: SEC Charges Microcap Fraudsters for Roles in Lucrative Market Manipulation Schemes 36

May 01, 2018: OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories 37

Mar 01, 2018: OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results 38

Nov 08, 2017: OPKO Health Reports 2017 Third Quarter Highlights and Financial Results 40

Sep 19, 2017: OPKO's BioReference Laboratories and The Garage Announce National Strategic Affiliation to Enhance Value-Based Care 41

Sep 12, 2017: OPKO's GeneDx to Showcase Leadership in Genetic Testing at the National Society of Genetic Counselors and the American Society of Human Genetics Annual Meetings 42

Sep 06, 2017: Sandra Cole Appointed Vice President and Chief Compliance Officer for OPKO's BioReference Laboratories 43

Aug 21, 2017: Update: Victoria Laughman Named Executive Vice President of Sales for OPKO's BioReference Laboratories 44

Aug 17, 2017: Victoria Laughman Named Executive Vice President of Sales for OPKO's BioReference Laboratories 45

Aug 08, 2017: OPKO Health Reports Second Quarter 2017 Business and Financial Results 46

Section 6-Appendix 48

Methodology 48

Ratio Definitions 48

About GlobalData 52

Contact Us 52

Disclaimer 52

List of Figures

OPKO Health Inc, Performance Chart (2013-2017) 30

OPKO Health Inc, Ratio Charts 32

OPKO Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

OPKO Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 34

List of Tables

OPKO Health Inc, Key Facts 6

OPKO Health Inc, Key Employees 7

OPKO Health Inc, Key Employee Biographies 8

OPKO Health Inc, Major Products and Services 9

OPKO Health Inc, History 10

OPKO Health Inc, Other Locations 14

OPKO Health Inc, Subsidiaries 14

OPKO Health Inc, Key Competitors 26

OPKO Health Inc, Ratios based on current share price 27

OPKO Health Inc, Annual Ratios 28

OPKO Health Inc, Annual Ratios (Cont...1) 29

OPKO Health Inc, Interim Ratios 31

OPKO Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

OPKO Health Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 34

OPKO Health Inc, Recent Deals Summary 35

Currency Codes 48

Capital Market Ratios 48

Equity Ratios 49

Profitability Ratios 49

Cost Ratios 50

Liquidity Ratios 50

Leverage Ratios 51

Efficiency Ratios 51

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Quest Diagnostics Inc

Laboratory Corp of America Holdings

Siemens Healthcare GmbH

Novartis AG

OPKO Health Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8918
Site License
USD 250 INR 17835
Corporate User License
USD 375 INR 26753

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com